(Q55463307)

12 July 2018

title

Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. (English)

1 reference

12 July 2018

author name string

Dildar Bahar Genc

series ordinal

1

1 reference

12 July 2018

Cengiz Canpolat

series ordinal

2

1 reference

12 July 2018

Su Gulsun Berrak

series ordinal

3

1 reference

12 July 2018

publication date

17 March 2011

1 reference

12 July 2018

Supportive Care in Cancer

published in

1 reference

12 July 2018

volume

20

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

385-393

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/s00520-011-1123-y

exact match

0 references

cites work

Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Pediatric adverse drug events in the outpatient setting: an 11-year national analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Carboplatin hypersensitivity in children. A report of five patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Visual pathway glioma in children treated with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Phase II study of carboplatin in children with progressive low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Hypersensitivity reactions to carboplatin in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1123-Y

Active monitoring of adverse drug reactions in children. Italian Paediatric Pharmacosurveillance Multicenter Group

21 January 2018

1 reference

12 December 2020

Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade g

1 reference

12 December 2020

Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study

1 reference

12 December 2020

Central nervous system tumors

1 reference

12 December 2020

Carboplatin desensitization

1 reference

12 December 2020

Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review

1 reference

12 December 2020

Safety and efficacy of repeated monthly carboplatin desensitization

1 reference

12 December 2020

Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity

1 reference

12 December 2020

Weekly dosing of carboplatin increases risk of allergy in children.

1 reference

12 December 2020

Hypersensitivity to carboplatin in children

1 reference

12 December 2020

Development and implementation of a carboplatin desensitization protocol for children with neurofibromatosis, type 1 and hypersensitivity reactions in an outpatient oncology clinic

1 reference

12 December 2020

10.1007/S00520-011-1123-Y

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018